Oncotarget

Editors-In-Chief and Editorial Board Members

Editorial Board

New members as of July 2024:



Two members of Oncotarget Editorial Board are Nobel Prize winners : Andrew V. Schally ( Physiology or Medicine 1977); Gregg L. Semenza ( Physiology or Medicine 2019)

Since 2013, four members of Oncotarget/Oncoscience/Gerotarget have won the Breakthrough Prize, the highest prize ever: Bert Vogelstein, Michael N. Hall, Alexander Varshavsky, Stephen J. Elledge


It is with sadness that we share the passing of our Editorial Board Member, Arthur B. Pardee, who died February 24, 2019 at the age of 97.

Dr. Pardee (1921-2019), member of the National Academy of Sciences, Professor of Biological Chemistry and Molecular Pharmacology Emeritus, Harvard Medical School, was a renowned cancer biologist who made several groundbreaking discoveries in the mid-20th century that shaped modern molecular biology.

We have been honored to have Dr. Pardee as a Founding Editor of Oncotarget.


It is with great sadness that we share the passing of Joseph R. Bertino, MD, the founding Editor of Oncotarget.

For more than 50 years, Joseph R. Bertino, MD, has devoted his life to improving therapies for cancer and hematologic disorders and has contributed his expertise toward establishing the foundation of modern cancer research. Dr. Bertino is internationally recognized for his role in finding curative treatments for leukemia and lymphoma. He was the past president of The American Association for Cancer Research (AACR) and American Society of Clinical Oncology (ASCO). He received many awards throughout his career including, but not limited to, the AACR Lifetime Achievement in Cancer Research Award, the University of Texas MD Anderson Cancer Center Jeffrey A. Gottlieb Memorial Award, and the LRF Key to the Cure Award and Freundlich Leadership Award.



Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC